119736-16-2Relevant articles and documents
Purification and characterization of molybdenum-containing aldehyde dehydrogenase that oxidizes benzyl maltol derivative from Pseudomonas nitroreducens SB32154
Hibi, Makoto,Kozono, Iori,Ogawa, Jun,Takeuchi, Michiki
, p. 2390 - 2400 (2020)
Maltol derivatives are used in a variety of fields due to their metal-chelating abilities. In the previous study, it was found that cytochrome P450 monooxygenase, P450nov, which has the ability to effectively convert the 2-methyl group in a maltol derivative, transformed 3-benzyloxy-2-methyl-4-pyrone (BMAL) to 2-(hydroxymethyl)-3-(phenylmethoxy)-4H-pyran-4-one (BMAL-OH) and slightly to 3-benzyloxy-4-oxo-4 H-pyran-2-carboxaldehyde (BMAL-CHO). We isolated Pseudomonas nitroreducens SB32154 with the ability to convert BMAL-CHO to BMAL-COOH from soil. The enzyme responsible for aldehyde oxidation, a BMAL-CHO dehydrogenase, was purified from P. nitroreducens SB32154 and characterized. The purified BMAL-CHO dehydrogenase was found to be a xanthine oxidase family enzyme with unique structure of heterodimer composed of 75 and 15 kDa subunits containing a molybdenum cofactor and [Fe-S] clusters, respectively. The enzyme showed broad substrate specificity toward benzaldehyde derivatives. Furthermore, one-pot conversion of BMAL to BMAL-COOH via BMAL-CHO by the combination of the BMAL-CHO dehydrogenase with P450nov was achieved.
Preparation method of intermediate of antiviral drug
-
Paragraph 0077-0080, (2021/06/22)
The invention relates to a preparation method of an intermediate of an antiviral drug, belonging to the field of medicinal chemistry. According to the method provided by the invention, raw materials react with an alkene forming reagent under the condition that Lewis acid and acid anhydride are added to prepare an intermediate compound; and then the intermediate compound reacts under the action of sodium periodate, and then post-treatment is conducted under the conditions of alkali and an oxidizing agent to obtain the intermediate. According to the method disclosed by the invention, reagents with relatively high toxicity or relatively high price and conditions such as extremely low temperature which is difficult to reach or control are not needed, used reagents are cheap and easy to obtain, reaction conditions are easy to control and implement, and the method has relatively high industrial application value.
Synthesis method of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid
-
, (2021/03/31)
The invention discloses a synthesis method of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid. The synthesis method sequentially comprises the following steps: S1, condensing 4-chloroacetoacetate and benzyl alcohol to obtain an intermediate I; S2, condensing the intermediate I with N,N-dimethylformamide dimethyl acetal to obtain an intermediate II; S3, performing ring closing on the intermediate IIand oxalic acid diester to obtain an intermediate III; and S4, decarboxylating the intermediate III in an acidic aqueous solution to obtain a target product. The method has the advantages of simple steps, mild conditions, cheap and easily available raw materials, and reduction of the cost of a target patent medicine.
Method for preparing baloxavir intermediate
-
Paragraph 0039; 0046-0049; 0056-0059; 0066-0068, (2021/01/11)
The invention belongs to the technical field of chemical synthesis and provides a method for preparing a balosavir intermediate. According to the method disclosed by the invention, cheap and easily available 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-ketone (a compound shown as a formula I) is used as a starting material; TEMPO oxidation, benzyl protection and hydrolysis reaction are carried out; so that the intermediate compound---3-benzyloxy-4-oxo-4H-pyran-2-formic acid shown as a formula Baloxavir is prepared. According to the method, highly toxic chemicals such as methylsulfonyl chloride and selenium dioxide are prevented from being used, and reaction reagents are common materials. In each step of the method, the temperature is controlled below 60 DEG C, high-temperature reaction is avoided, and the safety coefficient is high. The method has the advantages of short synthesis route, short reaction steps, simple operation, common and easily purchased reagents and low price, and suitability for industrial production.
Preparation method of pyrone compound
-
Paragraph 0042; 0051-0054, (2020/09/23)
The invention provides a preparation method of a pyrone compound, and belongs to the field of pharmaceutical chemicals. According to the method, a pyrone compound sequentially reacts with acetal, concentrated sulfuric acid and sodium chlorite respectively, and extraction is performed to obtain a high-purity pyrone compound. The product produced by the method has the characteristics of high purity,high yield, low cost, simple operation and stable process.
STEREOSELECTIVE PROCESS FOR PREPARING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES
-
, (2020/08/20)
The present invention provides industrially suitable processes for preparing intermediates in the production of substituted polycyclic pyridone derivatives having a cap-dependent endonuclease inhibitory activity. In the process as shown below, wherein each symbol is as defined in the specification, an optically active substituted tricyclic pyridone derivative of the formula (VII) is obtained in high yield and high enantioselectivity by subjecting a compound of the formula (III) or (VI) to intramolecular cyclization with controlling stereochemistry to obtain a compound of the formula (IV) having a removable functional group on an asymmetric carbon, and then removing the functional group thereof.
Pyridone [1, 2-b] [1,5] triazepine derivatives as well as preparation and application thereof (by machine translation)
-
Paragraph 0062; 0068-0069, (2020/12/30)
The invention discloses a hydroxypyridone [1, a-b] [1,5] triazepine derivatives as well as preparation and application thereof. Experiments prove that the hydroxypyridinone [1, 2-b] [1,triazepine derivatives (general formula I) have a good inhibition effect on the RNA polymerase activity of influenza A virus RNA, and can be used as an influenza virus RNA polymerase inhibitor to treat influenza caused by influenza virus. General Formula I is as follows. (by machine translation)
Spiro pyridone derivative and application
-
Paragraph 0049; 0056-0057, (2020/12/29)
The invention discloses a spiro pyridone derivative which has a structure shown in a general formula I in the specification. Researches show that the spiro pyridinone derivative has a relatively strong inhibition effect on the activity of influenza A virus RNA polymerase, and can be applied to the preparation of influenza A virus RNA polymerase activity inhibition and influenza A resistance medicines. The general formula I is shown in the specification.
PYRIDOPYRAZINE AND PYRIDOTRIAZINE INHIBITORS OF INFLUENZA VIRUS REPLICATION
-
Paragraph 00267; 00269, (2020/05/06)
Provided herein are compounds that can inhibit the replication of influenza viruses, reduce the amount of influenza viruses, and/or treat influenza. (I)
Preparation method of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid
-
Paragraph 0031-0032; 0036, (2019/10/01)
The invention relates to a novel synthesis route of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid. 3-hydroxy-2-methyl-4H-pyran-4-one used as a raw material undergoes acetyl protection, a brominationreaction, benzyl protection and oxidation reaction to synthesize a dolutegravir intermediate in four steps at a high yield. The above preparation method of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid has the advantages of high yield, low cost, environmental protection, easiness operation, and suitableness for realizing industrialization.